Esperion Therapeutics
ESPR
#7755
Rank
C$0.37 B
Marketcap
$1.88
Share price
-4.68%
Change (1 day)
-51.98%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -$3.82

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.99. In 2022 the company made an earnings per share (EPS) of -$5.03 an increase over its 2021 EPS that were of -$13.53.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.82-24.06%
2022-$5.03-62.87%
2021-$13.5380.38%
2020-$7.5050.14%
2019-$5.00-53.18%
2018-$10.687.41%
2017-$9.94110.81%
2016-$4.7147.35%
2015-$3.200.89%
2014-$3.1728.84%
2013-$2.46-89.3%
2012-$23.01
2002-$9.698.89%
2001-$8.90-83.77%
2000-$54.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$14.50 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.10-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.63-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$52.89-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.91-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.96-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA